Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Agenus Current Ratio 2006-2019 | AGEN

Agenus current ratio from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
Agenus Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-12-31 $0.09B $0.12B 0.71
2019-09-30 $0.11B $0.13B 0.81
2019-06-30 $0.14B $0.12B 1.14
2019-03-31 $0.18B $0.11B 1.70
2018-12-31 $0.08B $0.07B 1.10
2018-09-30 $0.07B $0.06B 1.16
2018-06-30 $0.07B $0.05B 1.32
2018-03-31 $0.07B $0.03B 2.16
2017-12-31 $0.07B $0.06B 1.30
2017-09-30 $0.08B $0.05B 1.55
2017-06-30 $0.11B $0.03B 3.36
2017-03-31 $0.14B $0.04B 3.80
2016-12-31 $0.09B $0.04B 2.24
2016-09-30 $0.11B $0.04B 3.14
2016-06-30 $0.14B $0.03B 4.12
2016-03-31 $0.16B $0.03B 5.17
2015-12-31 $0.18B $0.03B 6.36
2015-09-30 $0.21B $0.03B 7.39
2015-06-30 $0.15B $0.03B 5.78
2015-03-31 $0.09B $0.02B 4.06
2014-12-31 $0.04B $0.01B 4.62
2014-09-30 $0.06B $0.02B 3.54
2014-06-30 $0.07B $0.02B 3.61
2014-03-31 $0.08B $0.01B 5.24
2013-12-31 $0.03B $0.01B 2.74
2013-09-30 $0.03B $0.01B 3.20
2013-06-30 $0.01B $0.01B 2.01
2013-03-31 $0.02B $0.01B 3.18
2012-12-31 $0.02B $0.01B 4.70
2012-09-30 $0.03B $0.01B 5.34
2012-06-30 $0.03B $0.01B 5.77
2012-03-31 $0.03B $0.01B 4.71
2011-12-31 $0.01B $0.01B 2.53
2011-09-30 $0.02B $0.01B 2.73
2011-06-30 $0.01B $0.01B 2.77
2011-03-31 $0.02B $0.01B 3.03
2010-12-31 $0.02B $0.01B 3.85
2010-09-30 $0.03B $0.04B 0.64
2010-06-30 $0.03B $0.01B 6.25
2010-03-31 $0.03B $0.01B 4.57
2009-12-31 $0.03B $0.01B 5.89
2009-09-30 $0.04B $0.01B 5.81
2009-06-30 $0.02B $0.01B 3.51
2009-03-31 $0.03B $0.01B 4.36
2008-12-31 $0.04B $0.01B 5.07
2008-09-30 $0.04B $0.01B 4.66
2008-06-30 $0.05B $0.01B 5.97
2008-03-31 $0.04B $0.01B 4.77
2007-12-31 $0.02B $0.01B 2.48
2007-09-30 $0.03B $0.01B 3.24
2007-06-30 $0.03B $0.01B 3.75
2007-03-31 $0.04B $0.01B 5.03
2006-12-31 $0.04B $0.01B 4.66
2006-09-30 $0.03B $0.01B 2.51
2006-06-30 $0.04B $0.01B 2.68
2006-03-31 $0.05B $0.02B 3.29
2005-12-31 $0.07B $0.02B 3.50
2005-09-30 $0.08B $0.02B 4.52
2005-06-30 $0.10B $0.02B 4.92
2005-03-31 $0.12B $0.02B 6.83
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.383B $0.150B
Agenus Inc., formerly known as Antigenics Inc., is engaged in the discovery, development and commercialization of immunotherapeutics for the treatment of life threatening and chronic medical conditions. Immunotherapeutics are drugs that work by modulating the immune system to fight diseases. The Company's product line includes Oncophage vaccine, a patient-specific therapeutic cancer vaccine. The Company is also developing Prophage, patient-specific therapeutic cancer vaccine; QS-21, vaccine adjuvant; and HerpV, a polyvalent off-the-shelf therapeutic heat shock protein-based vaccine for treatment of genital herpes which are all in the clinical testing stages. Agenus Inc. is headquartered in Lexington, Massachusetts.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $123.199B 14.09
Gilead Sciences (GILD) United States $96.919B 12.54
CSL (CSLLY) Australia $87.050B 0.00
Vertex Pharmaceuticals (VRTX) United States $62.784B 56.98
Regeneron Pharmaceuticals (REGN) United States $54.871B 23.24
Biogen (BIIB) United States $52.997B 9.05
Illumina (ILMN) United States $40.130B 41.49
Seattle Genetics (SGEN) United States $20.442B 0.00
Alexion Pharmaceuticals (ALXN) United States $20.067B 9.30
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.372B 0.00
Incyte (INCY) United States $16.707B 35.85
BioMarin Pharmaceutical (BMRN) United States $15.484B 662.00
Genmab (GMAB) Denmark $13.068B 10.25
BioNTech SE (BNTX) Germany $12.877B 0.00
Genmab (GNMSF) Denmark $12.366B 39.77
Galapagos (GLPG) Belgium $12.288B 26.84
Alnylam Pharmaceuticals (ALNY) United States $11.783B 0.00
Moderna (MRNA) United States $10.923B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.315B 48.21
QIAGEN (QGEN) Netherlands $9.133B 27.85
BeiGene (BGNE) Cayman Islands $8.882B 0.00
Exact Sciences (EXAS) United States $8.523B 0.00
Sarepta Therapeutics (SRPT) United States $7.465B 0.00
Bio-Techne Corp (TECH) United States $7.318B 50.08
ACADIA Pharmaceuticals (ACAD) United States $6.475B 0.00
Guardant Health (GH) United States $6.146B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.056B 16.00
ARGENX SE-ADR (ARGX) Netherlands $5.695B 0.00
Ascendis Pharma (ASND) Denmark $5.293B 0.00
Exelixis (EXEL) United States $5.085B 16.32
Repligen (RGEN) United States $5.050B 92.33
Reata Pharmaceuticals (RETA) United States $4.498B 0.00
Acceleron Pharma (XLRN) United States $4.459B 0.00
China Biologic Products (CBPO) China $4.023B 23.88
Adaptive Biotechnologies (ADPT) United States $3.553B 0.00
Mirati Therapeutics (MRTX) United States $3.278B 0.00
Blueprint Medicines (BPMC) United States $3.263B 0.00
Vir Biotechnology (VIR) United States $3.213B 0.00
MorphoSys AG (MOR) Germany $3.186B 0.00
Global Blood Therapeutics (GBT) United States $3.076B 0.00
Zai Lab (ZLAB) China $2.992B 0.00
Emergent Biosolutions (EBS) United States $2.966B 20.59
Ultragenyx Pharmaceutical (RARE) United States $2.896B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.845B 0.00
NeoGenomics (NEO) United States $2.834B 122.86
Amicus Therapeutics (FOLD) United States $2.472B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.404B 40.73
Bluebird Bio (BLUE) United States $2.370B 0.00
Halozyme Therapeutics (HALO) United States $2.329B 0.00
Immunomedics (IMMU) United States $2.278B 0.00
RA PHARMCTL INC (RARX) United States $2.272B 0.00
Alkermes (ALKS) Ireland $2.212B 175.25
Arena Pharmaceuticals (ARNA) United States $2.210B 5.76
MyoKardia (MYOK) United States $2.161B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.102B 0.00
UniQure (QURE) Netherlands $2.078B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.977B 0.00
Amarin (AMRN) Ireland $1.865B 0.00
Denali Therapeutics (DNLI) United States $1.839B 0.00
Alector (ALEC) United States $1.786B 0.00
Principia Biopharma (PRNB) United States $1.731B 0.00
Eidos Therapeutics (EIDX) United States $1.647B 0.00
Viela Bio (VIE) United States $1.631B 0.00
Fate Therapeutics (FATE) United States $1.600B 0.00
Arvinas (ARVN) United States $1.565B 0.00
Zymeworks (ZYME) Canada $1.563B 0.00
Akcea Therapeutics (AKCA) United States $1.463B 31.46
Epizyme (EPZM) United States $1.437B 0.00
Insmed (INSM) United States $1.357B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.350B 0.00
Ligand Pharmaceuticals (LGND) United States $1.188B 36.90
Zealand Pharma (ZEAL) Denmark $1.144B 0.00
PHARMA MAR SA (PHMMF) Spain $1.107B 0.00
Editas Medicine (EDIT) United States $1.096B 0.00
Inovio Pharmaceuticals (INO) United States $1.096B 0.00
REGENXBIO (RGNX) United States $1.093B 0.00
Coherus BioSciences (CHRS) United States $1.057B 12.57
Twist Bioscience (TWST) United States $1.055B 0.00
Myriad Genetics (MYGN) United States $0.992B 17.51
NextCure (NXTC) United States $0.987B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
NGM Biopharmaceuticals (NGM) United States $0.866B 0.00
I-Mab (IMAB) China $0.827B 0.00
Intra-Cellular Therapies (ITCI) United States $0.795B 0.00
Sangamo Therapeutics (SGMO) United States $0.787B 0.00
Revance Therapeutics (RVNC) United States $0.779B 0.00
Beam Therapeutics (BEAM) United States $0.758B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.740B 0.00
Cytokineticsorporated (CYTK) United States $0.716B 0.00
Novavax (NVAX) United States $0.714B 0.00
Arcus Biosciences (RCUS) United States $0.685B 0.00
Adverum Biotechnologies (ADVM) United States $0.680B 0.00
Pharming Group (PHGUF) Netherlands $0.663B 0.00
Bellus Health (BLU) Canada $0.663B 0.00
Athenex (ATNX) United States $0.658B 0.00
Retrophin (RTRX) United States $0.648B 0.00
Kadmon Holdings (KDMN) United States $0.617B 0.00
Codexis (CDXS) United States $0.613B 0.00
Cara Therapeutics (CARA) United States $0.593B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.591B 5.20
Intellia Therapeutics (NTLA) United States $0.582B 0.00
GENFIT S.A (GNFT) France $0.577B 0.00
AC Immune SA (ACIU) Switzerland $0.512B 13.07
ZIOPHARM Oncology Inc (ZIOP) United States $0.509B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.501B 0.00
Compugen (CGEN) Israel $0.497B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.489B 0.00
Mesoblast (MESO) Australia $0.486B 0.00
Intrexon (PGEN) United States $0.485B 0.00
Castle Biosciences (CSTL) United States $0.477B 0.00
Frequency Therapeutics (FREQ) United States $0.474B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.469B 0.00
ANI Pharmaceuticals (ANIP) United States $0.469B 8.46
Heska (HSKA) United States $0.469B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.460B 0.00
Prothena (PRTA) Ireland $0.459B 0.00
Athersys (ATHX) United States $0.450B 0.00
Clovis Oncology (CLVS) United States $0.446B 0.00
MeiraGTx Holdings (MGTX) United States $0.434B 0.00
Morphic Holding (MORF) United States $0.433B 0.00
DBV Technologies S.A (DBVT) France $0.430B 0.00
Anika Therapeutics (ANIK) United States $0.421B 14.48
Aquinox Pharmaceuticals (NLTX) United States $0.414B 0.00
Verastem (VSTM) United States $0.411B 0.00
Vericel (VCEL) United States $0.387B 57.47
Xenon Pharmaceuticals (XENE) Canada $0.384B 0.00
Scholar Rock Holding (SRRK) United States $0.381B 0.00
Cel-Sci (CVM) United States $0.374B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.373B 0.00
AnaptysBio (ANAB) United States $0.368B 0.00
Sorrento Therapeutics (SRNE) United States $0.366B 0.00
BioDelivery Sciences (BDSI) United States $0.364B 42.00
MiMedx (MDXG) United States $0.361B 0.00
UROGEN PHARMA (URGN) United States $0.355B 0.00
Cellectis S.A (CLLS) France $0.349B 0.00
Kala Pharmaceuticals (KALA) United States $0.346B 0.00
CytomX Therapeutics (CTMX) United States $0.340B 0.00
Cue Biopharma (CUE) United States $0.338B 0.00
PDL BioPharma (PDLI) United States $0.337B 10.11
Merus (MRUS) Netherlands $0.319B 0.00
Cellular Biomedicine (CBMG) United States $0.298B 0.00
Dynavax Technologies (DVAX) United States $0.298B 0.00
Pfenex (PFNX) United States $0.298B 435.00
Syndax Pharmaceuticals (SNDX) United States $0.295B 0.00
Puma Biotechnology (PBYI) United States $0.286B 0.00
Precision BioSciences (DTIL) United States $0.285B 0.00
WAVE Life Sciences (WVE) Singapore $0.279B 0.00
Avid Bioservices (CDMO) United States $0.264B 0.00
NantKwest (NK) United States $0.261B 0.00
Kamada (KMDA) Israel $0.252B 10.50
Syros Pharmaceuticals (SYRS) United States $0.249B 0.00
Mersana Therapeutics (MRSN) United States $0.244B 0.00
Sutro Biopharma (STRO) United States $0.235B 0.00
Albireo Pharma (ALBO) United States $0.234B 0.00
Stemline Therapeutics (STML) United States $0.234B 0.00
Gritstone Oncology (GRTS) United States $0.231B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.226B 0.00
Seres Therapeutics (MCRB) United States $0.225B 0.00
ADMA Biologics Inc (ADMA) United States $0.224B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.218B 0.00
Geron (GERN) United States $0.210B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.208B 0.00
Aduro Biotech (ADRO) United States $0.203B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.202B 1.82
MannKind (MNKD) United States $0.200B 0.00
Alcobra (ARCT) United States $0.192B 0.00
Starpharma Holdings (SPHRY) Australia $0.186B 0.00
ChromaDex (CDXC) United States $0.185B 0.00
XOMA (XOMA) United States $0.180B 0.00
Abeona Therapeutics (ABEO) United States $0.176B 0.00
Protagonist Therapeutics (PTGX) United States $0.171B 0.00
HOOKIPA Pharma (HOOK) United States $0.168B 0.00
Selecta Biosciences (SELB) United States $0.164B 0.00
VBI Vaccines (VBIV) United States $0.164B 0.00
IVERIC Bio (ISEE) United States $0.159B 0.00
Biofrontera AG (BFRA) Germany $0.159B 0.00
OSMOTICA PHARM (OSMT) United States $0.154B 0.00
Prometic Life Sciences (LMNL) Canada $0.151B 0.00
Kindred Biosciences (KIN) United States $0.151B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.150B 0.00
POXEL SA FRANCE (PXXLF) France $0.149B 0.00
Spero Therapeutics (SPRO) United States $0.148B 0.00
Liquidia Technologies (LQDA) United States $0.147B 0.00
Fortress Biotech (FBIO) United States $0.144B 0.00
Aytu Bioscience (AYTU) United States $0.143B 0.00
Dyadic (DYAI) United States $0.138B 0.00
AIT Therapeutics (XAIR) United States $0.136B 0.00
Theratechnologies (THTX) Canada $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
VolitionRX (VNRX) United States $0.133B 0.00
Windtree Therapeutics (WINT) United States $0.131B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.127B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.126B 0.00
Affimed (AFMD) Germany $0.125B 0.00
Cerecor (CERC) United States $0.123B 0.00
Antibe Therapeutics (ATBPF) Canada $0.120B 0.00
Exicure (XCUR) United States $0.118B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.117B 0.00
VTv Therapeutics (VTVT) United States $0.117B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.114B 4.49
Enzo Biochem (ENZ) United States $0.107B 0.00
Strongbridge Biopharma (SBBP) United States $0.105B 0.00
IBio (IBIO) United States $0.104B 0.00
Northwest Biotherapeutics (NWBO) United States $0.104B 0.00
Celyad SA (CYAD) Belgium $0.102B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.099B 0.00
Cidara Therapeutics (CDTX) United States $0.097B 0.00
Palatin Technologies (PTN) United States $0.096B 2.61
OvaScience (MLND) United States $0.091B 0.00
Aptinyx (APTX) United States $0.089B 0.00
TELA Bio (TELA) United States $0.088B 0.00
PHASEBIO PHARMA (PHAS) United States $0.087B 0.00
Orgenesis (ORGS) United States $0.081B 4.72
CorMedix Inc (CRMD) United States $0.080B 0.00
ARAVIVE, INC (ARAV) United States $0.078B 0.00
Five Prime Therapeutics (FPRX) United States $0.077B 0.00
Happiness Biotech Group (HAPP) China $0.077B 0.00
Clearside Biomedical (CLSD) United States $0.072B 0.00
Arbutus Biopharma (ABUS) Canada $0.069B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.069B 0.00
Eton Pharmaceuticals (ETON) United States $0.066B 0.00
Adocia (ADOCY) France $0.066B 0.00
Cyclerion Therapeutics (CYCN) United States $0.066B 0.00
Checkpoint Therapeutics (CKPT) United States $0.066B 0.00
Menlo Therapeutics (MNLO) United States $0.065B 0.00
Emmaus Life Sciences (EMMA) United States $0.059B 0.00
Applied Genetic Technologies (AGTC) United States $0.059B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.059B 0.00
Pluristem Therapeutics (PSTI) Israel $0.059B 0.00
Vaccinex (VCNX) United States $0.059B 0.00
SESEN BIO, INC (SESN) United States $0.058B 0.00
Proteostasis Therapeutics (PTI) United States $0.054B 0.00
AquaBounty Technologies (AQB) United States $0.053B 0.00
Synlogic (SYBX) United States $0.051B 0.00
Trevena (TRVN) United States $0.049B 0.00
Catalyst Biosciences (CBIO) United States $0.048B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.047B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.047B 0.00
Stealth BioTherapeutics (MITO) United States $0.046B 0.00
Vascular Biogenics (VBLT) Israel $0.044B 0.00
Acorda Therapeutics (ACOR) United States $0.041B 0.00
Idera Pharmaceuticals (IDRA) United States $0.038B 0.00
Cocrystal Pharma (COCP) United States $0.038B 0.00
Soligenix (SNGX) United States $0.035B 0.00
AmpliPhi Biosciences (ARMP) United States $0.034B 0.00
Organovo Holdings (ONVO) United States $0.033B 0.00
Protalix BioTherapeutics (PLX) Israel $0.033B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.032B 0.00
Lumos Pharma (LUMO) United States $0.032B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.032B 0.00
CollPlant Holdings (CLGN) Israel $0.032B 0.00
Advaxis (ADXS) United States $0.032B 0.00
DiaMedica Therapeutics (DMAC) United States $0.031B 0.00
Celldex Therapeutics (CLDX) United States $0.029B 0.00
Prima BioMed (IMMP) Australia $0.028B 0.00
Celsion (CLSN) United States $0.027B 0.00
Pulmatrix (PULM) United States $0.026B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.025B 0.00
TOCAGEN INC (TOCA) United States $0.025B 0.00
Curis (CRIS) United States $0.024B 0.00
Evogene (EVGN) Israel $0.024B 0.00
BioCardia (BCDA) United States $0.023B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
Entera Bio (ENTX) Israel $0.022B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
Novogen (KZIA) Australia $0.019B 0.00
Stellar Biotechnologies (EDSA) Canada $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
Oncobiologics (OTLK) United States $0.017B 0.00
Alimera Sciences (ALIM) United States $0.017B 0.00
Apricus Biosciences (SEEL) United States $0.015B 0.00
Titan Pharmaceuticals (TTNP) United States $0.015B 0.00
VIVUS (VVUS) United States $0.014B 0.00
Cesca Therapeutics (THMO) United States $0.011B 0.00
Unum Therapeutics (UMRX) United States $0.011B 0.00
AEterna Zentaris (AEZS) United States $0.011B 0.00
Aptevo Therapeutics (APVO) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
ATyr Pharma (LIFE) United States $0.010B 0.00
Bionano Genomics (BNGO) United States $0.010B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
TrovaGene (TROV) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
TRACON Pharmaceuticals (TCON) United States $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
IMMURON (IMRN) Australia $0.006B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Spherix (AIKI) United States $0.003B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00